Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Nita Lee

TitleAssociate Professor
InstitutionUniversity of Chicago
DepartmentObstetrics and Gynecology-Gynecologic Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Nita Karnik Lee, MD, specializes in the diagnosis and treatment of women with gynecologic malignancies. Her focus is on providing comprehensive and compassionate care to women diagnosed with ovarian, uterine, cervical, vulvar or vaginal cancers. She is skilled in minimally invasive surgical techniques, including robotic surgery for gynecologic cancers and complex benign gynecologic conditions.

    Dr. Lee’s research interests include cancer survivorship, cancer disparities, and clinical trials focusing on new therapies for ovarian, uterine and cervical cancers. She is an active member of the Gynecologic Oncology Group (GOG), a cooperative research group supported by the National Cancer Institute.

    Her recent funded research focuses on endometrial cancer survivorship and the importance of healthy lifestyle change after diagnosis. She is also interested in the screening, prevention, and early detection of gynecologic cancers by educating providers and patients.


    Collapse Biography 
    Collapse education and training
    Tulane UniversityMD
    Northwestern Memorial HospitalInternship
    Northwestern Memorial HospitalResidency
    University of California, San Francisco; Stanford University HospitalFellowship

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ackroyd SA, Huang ES, Kurnit KC, Lee NK. Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis. Gynecol Oncol. 2021 Aug; 162(2):249-255. PMID: 34103196.
      View in: PubMed
    2. Goldberg EM, Berger Y, Sood D, Kurnit KC, Kim JS, Lee NK, Yamada SD, Turaga KK, Eng OS. ASO Visual Abstract: Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer. Ann Surg Oncol. 2021 May 12. PMID: 33978887.
      View in: PubMed
    3. Goldberg EM, Berger Y, Sood D, Kurnit KC, Kim JS, Lee NK, Yamada SD, Turaga KK, Eng OS. Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer. Ann Surg Oncol. 2021 May 06. PMID: 33959831.
      View in: PubMed
    4. Jani I, Lastra RR, Brito KS, Liao C, Lazo I, Lee NK, Yamada SD, Kurnit KC. Chemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy. Int J Gynecol Cancer. 2021 06; 31(6):852-858. PMID: 33833085.
      View in: PubMed
    5. Lindau ST, Makelarski JA, Boyd K, Doyle KE, Haider S, Kumar S, Lee NK, Pinkerton E, Tobin M, Vu M, Wroblewski KE, Lengyel E. Change in Health-Related Socioeconomic Risk Factors and Mental Health During the Early Phase of the COVID-19 Pandemic: A National Survey of U.S. Women. J Womens Health (Larchmt). 2021 04; 30(4):502-513. PMID: 33818123.
      View in: PubMed
    6. Farley JH, Hines J, Lee NK, Brooks SE, Nair N, Brown CL, Doll KM, Sullivan EJ, Chapman-Davis E. Promoting health equity in the era of COVID-19. Gynecol Oncol. 2020 07; 158(1):25-31. PMID: 32446719.
      View in: PubMed
    7. Hoppenot C, Hlubocky FJ, Chor J, Yamada SD, Lee NK. Approach to Palliative Care Consultation for Patients With Malignant Bowel Obstruction in Gynecologic Oncology: A Qualitative Analysis of Physician Perspectives. JCO Oncol Pract. 2020 08; 16(8):483-489. PMID: 32240072.
      View in: PubMed
    8. Brooks RA, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH, Tatebe K, Veneris JL. Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin. 2019 07; 69(4):258-279. PMID: 31074865.
      View in: PubMed
    9. Hoppenot C, Peters P, Cowan M, Moore ED, Hurteau J, Lee NK, Yamada SD. Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome? Gynecol Oncol. 2019 07; 154(1):177-182. PMID: 31056111.
      View in: PubMed
    10. Ross JGC, Escamilla V, Lee NK, Diane Yamada S, Lindau ST. Geospatial patterns of access to self-care resources for obesity among endometrial cancer survivors in a high poverty urban community. Gynecol Oncol. 2019 02; 152(2):322-327. PMID: 30581035.
      View in: PubMed
    11. Kim JS, Mills KA, Fehniger J, Liao C, Hurteau JA, Kirschner CV, Lee NK, Rodriguez GC, Yamada SD, Diaz Moore ES, Tenney ME. Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer. Int J Gynecol Cancer. 2017 10; 27(8):1774-1782. PMID: 28708786.
      View in: PubMed
    12. Feng CH, Miller CM, Tenney ME, Lee NK, Yamada SD, Hasan Y. Statin Use Significantly Improves Overall Survival in High-Grade Endometrial Cancer. Int J Gynecol Cancer. 2016 11; 26(9):1642-1649. PMID: 27654261.
      View in: PubMed
    13. Sampat A, Parakati I, Kunnavakkam R, Glick DB, Lee NK, Tenney M, Eggener S, Roth S. Corneal abrasion in hysterectomy and prostatectomy: role of laparoscopic and robotic assistance. Anesthesiology. 2015 May; 122(5):994-1001. PMID: 25734923.
      View in: PubMed
    14. Hunn J, Tenney ME, Tergas AI, Bishop EA, Moore K, Watkin W, Kirschner C, Hurteau J, Rodriguez GC, Lengyel E, Lee NK, Yamada SD. Patterns and utility of routine surveillance in high grade endometrial cancer. Gynecol Oncol. 2015 Jun; 137(3):485-9. PMID: 25838164.
      View in: PubMed
    15. Kennedy V, Abramsohn E, Makelarski J, Barber R, Wroblewski K, Tenney M, Lee NK, Yamada SD, Lindau ST. Can you ask? We just did! Assessing sexual function and concerns in patients presenting for initial gynecologic oncology consultation. Gynecol Oncol. 2015 Apr; 137(1):119-24. PMID: 25582823.
      View in: PubMed
    16. Buell-Gutbrod R, Cavallo A, Lee N, Montag A, Gwin K. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma. Int J Gynecol Pathol. 2015 Jan; 34(1):65-73. PMID: 25473755.
      View in: PubMed
    17. Matulonis UA, Lee J, Lasonde B, Tew WP, Yehwalashet A, Matei D, Behbakht K, Grothusen J, Fleming G, Lee NK, Arnott J, Bray MR, Fletcher G, Brokx RD, Castonguay V, Mackay H, Sidor CF, Oza AM. ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer. Eur J Cancer. 2013 Jan; 49(1):121-31. PMID: 22921155.
      View in: PubMed
    18. Song S, Rudra S, Hasselle MD, Dorn PL, Mell LK, Mundt AJ, Yamada SD, Lee NK, Hasan Y. The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy. Cancer. 2013 Jan 15; 119(2):325-31. PMID: 22806897.
      View in: PubMed
    19. Lee NK. Adjuvant treatment of advanced-stage endometrial cancer. Clin Obstet Gynecol. 2011 Jun; 54(2):256-65. PMID: 21508695.
      View in: PubMed
    20. Lee NK, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Kapp DS, Osann K, Chan JK. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol. 2007 Mar; 109(3):655-62. PMID: 17329517.
      View in: PubMed
    Lee's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _